ANTI-TRANSTHYRETIN ANTIBODIES
CY1125972T1Undetermined Publication Date: 2026-07-31UNIV HEALTH NETWORK
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20231100007T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2015-12-11
- Filing Date
- 2023-01-05
- Publication Date
- 2026-07-31
- Estimated Expiration
- 2043-01-05
Abstract
The invention provides antibodies that specifically bind transthyretin (TTR). The antibodies can be used to treat or prevent diseases or disorders associated with TTR accumulation or accumulation of TTR deposits (e.g., TTR amyloidosis). The antibodies can also be used to diagnose TTR amyloidosis and inhibit or reduce TTR accumulation, among other applications.
Need to check novelty before this filing date? Find Prior Art